Nothing Special   »   [go: up one dir, main page]

Jacobson, 2023 - Google Patents

Using Cyclic Immunofluorescence (CyCIF), Deep-learning, and Human Tumor Microarrays (hTMAs) for Antibody Validation and Creation of an Atlas of Cancers …

Jacobson, 2023

View PDF
Document ID
9934999438770016986
Author
Jacobson C
Publication year

External Links

Snippet

All cancers are different from each other, in their mutation spectrum, primary location of occurrence, and metastases as well as their phenotypic traits and tumor composition. For years, clinicians and pathologists have sought to describe, characterize, and exploit the …
Continue reading at dash.harvard.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458—Fluorescence microscopy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection

Similar Documents

Publication Publication Date Title
Berry et al. Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Steele et al. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
Lin et al. High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers
JP6605506B2 (en) Methods, kits, and systems for scoring immune responses against cancer by simultaneous detection of CD3, CD8, CD20 and FoxP3
EP2737454A1 (en) Method for providing images of a tissue section
WO2012125807A2 (en) Systems and compositions for diagnosing barrett's esophagus and methods of using the same
Bosisio et al. Next-generation pathology using multiplexed immunohistochemistry: mapping tissue architecture at single-cell level
Jhaveri et al. Mapping the spatial proteome of head and neck tumors: key immune mediators and metabolic determinants in the tumor microenvironment
Zidane et al. A review on deep learning applications in highly multiplexed tissue imaging data analysis
Zhao et al. Multiplex imaging in immuno-oncology
JP7011067B2 (en) Systems and methods for classifying cells in tissue images based on membrane characteristics
Park et al. Clinical characteristics of Korean patients with lung cancer who have programmed death-ligand 1 expression
Saini Nalini Bai Thakkar Award
Lin et al. Multi-modal digital pathology for colorectal cancer diagnosis by high-plex immunofluorescence imaging and traditional histology of the same tissue section
Kuczkiewicz-Siemion et al. The role of pathology-based methods in qualitative and quantitative approaches to cancer immunotherapy
Jacobson Using Cyclic Immunofluorescence (CyCIF), Deep-learning, and Human Tumor Microarrays (hTMAs) for Antibody Validation and Creation of an Atlas of Cancers Emphasizing Unique Phenotypes
US20240272161A1 (en) Method of predicting response to immunotherapy
Ffrench et al. CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity
Caranfil et al. Artificial Intelligence and Lung Pathology
Baker et al. Quality control for single cell analysis of high-plex tissue profiles using CyLinter
Williams et al. The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibition
Nakamura et al. Macroscopic qualitative evaluation of solid pancreatic lesion specimens from endoscopic ultrasound-guided fine needle aspiration/biopsies
Jenoski et al. Color calibration for digital cytology scanner
Dammak et al. Prediction of tumour mutational burden of squamous cell carcinoma using histopathology images of surgical specimens
Park et al. Seven-colour multiplex immunochemistry/immunofluorescence and whole slide imaging of frozen sections